tiprankstipranks
Trending News
More News >
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (HK:2196)
:2196

Shanghai Fosun Pharmaceutical (Group) Co (2196) Revenue

Compare
5 Followers

Shanghai Fosun Pharmaceutical (Group) Co Revenue

Shanghai Fosun Pharmaceutical (Group) Co had a revenue of 10.09B in the quarter ending Jun 30, 2025, with 7.15%. This bring the company's revenue in the last twelve months to 40.12B, Increased -0.52%. In the fiscal year ending Dec 31, 2024, Shanghai Fosun Pharmaceutical (Group) Co had annual revenue of 41.07B with -0.80% growth.
Revenue (ttm)
40.12B
Revenue Growth
-1.12%
P/S Ratio
1.81
Revenue/Employee
HK$1,012,580
Employees
40,557
Market Cap
HK$74.18B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
41.07B-332.34M+99.20%
Dec 31, 2023
41.40B-2.55B+94.19%
Dec 31, 2022
43.95B4.95B+112.68%
Dec 31, 2021
39.01B8.70B+128.70%
Dec 31, 2020
30.31B1.72B+106.02%
Dec 31, 2019
28.59B3.67B+114.72%
Dec 31, 2018
24.92B6.38B+134.45%
Dec 31, 2017
18.53B3.90B+126.69%
Dec 31, 2016
14.63B